Raymond James Trust N.A. Dexcom Inc Transaction History
Raymond James Trust N.A.
- $4.22 Billion
- Q2 2024
A detailed history of Raymond James Trust N.A. transactions in Dexcom Inc stock. As of the latest transaction made, Raymond James Trust N.A. holds 26,778 shares of DXCM stock, worth $1.85 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
26,778
Previous 25,750
3.99%
Holding current value
$1.85 Million
Previous $3.57 Million
14.98%
% of portfolio
0.07%
Previous 0.09%
Shares
17 transactions
Others Institutions Holding DXCM
# of Institutions
1,050Shares Held
358MCall Options Held
4.11MPut Options Held
3.63M-
Vanguard Group Inc Valley Forge, PA46.5MShares$3.21 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2.38 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.3MShares$1.12 Billion0.08% of portfolio
-
Baillie Gifford & CO15MShares$1.03 Billion0.77% of portfolio
-
Capital Research Global Investors Los Angeles, CA11.9MShares$823 Million0.31% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $26.6B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...